Back
HealthStream 10K Form
Buy
55
HSTM
HealthStream
Last Price:
31.81
Seasonality Move:
3.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | HSTM/HealthStream Quarterly |
2023-10-26 | 10Q | HSTM/HealthStream Quarterly |
2023-07-27 | 10Q | HSTM/HealthStream Quarterly |
2023-04-27 | 10Q | HSTM/HealthStream Quarterly |
2022-10-27 | 10Q | HSTM/HealthStream Quarterly |
2022-07-28 | 10Q | HSTM/HealthStream Quarterly |
Receive HSTM News And Ratings
See the #1 stock for the next 7 days that we like better than HSTM
HSTM Financial Statistics
Sales & Book Value
Annual Sales: | $279.06M |
---|---|
Cash Flow: | $12.27M |
Price / Cash Flow: | 29.47 |
Annual Sales: | $11.69 |
Price / Book: | 2.68 |
Profitability
EPS (TTM): | 0.65000 |
---|---|
Net Income (TTM): | $19.71M |
Gross Margin: | $184.04M |
Return on Equity: | 5.69% |
Return on Assets: | 3.92% |
HealthStream Earnings Forecast
Key HealthStream Financial Ratios
- The Gross Profit Margin over the past 25 years for HSTM is 65.95%.
- The Selling, General & Administrative Expenses for HSTM have been equal to 29.17% of Gross Profit Margin.
- The Research & Development expenses have been 16.32% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of HSTM is 5.45% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 15 years.
HealthStream Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | HSTM |
CUSIP: | 42222N |
Website: | healthstream.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.32 |
Quick Ratio: | 1.14 |
Price-to-Earnings
Trailing P/E Ratio: | 62.62 |
---|---|
Forward P/E Ratio: | 46.04 |
HSTM Technical Analysis vs Fundamental Analysis
Buy
55
HealthStream (HSTM)
is a Buy
Is HealthStream a Buy or a Sell?
-
HealthStream stock is rated a Buy
The current HealthStream [HSTM] share price is $31.30. The Score for HSTM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.